FDA clears Werfen’s ROTEM sigma complete cartridge for trauma use
Werfen received FDA 510(k) clearance for the ROTEM sigma complete cartridge to assess peri-operative hemorrhage and/or thrombosis in trauma in the United States.
6b0075aa826b56a240f97857 Rotem Sigma Complete Normal Trauma 0
Werfen has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the ROTEM sigma complete cartridge to assess peri-operative hemorrhage and/or thrombosis in trauma, according to an announcement.
The new indication extends the use of the ROTEM sigma viscoelastic testing system beyond cardiovascular surgery and liver transplantation, enabling bleeding management in the trauma setting within the United States.
ROTEM sigma is a fully automated viscoelastic testing system that delivers real-time assessment of clot initiation, clot firmness, and clot stability at the point of care. By providing timely information about a patient's coagulation status, the system supports individualized treatment strategies during critical bleeding events. ROTEM sigma results should be interpreted together with the patient's clinical condition and other laboratory tests.
Additional key features:
Fully automated cartridge-based system
Closed-tube direct sampling
Minimizes manual handling steps
Reduces operator-dependent variability
Automated assay initiation
Integrated quality control
Continuous internal system monitoring
Intuitive touchscreen operation
Room-temperature cartridge storage
Real-time visibility into coagulation dynamics
The full indications for use can be found on Werfen’s website.